VEGFR2/CD309 Antikörper
-
- Target Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigen
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser VEGFR2/CD309 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Immunogen
- Synthetic peptide: internal domain of human VEGF receptor 2, conjugated to Keyhole Limpet Hemocyanin (KLH).
- Isotyp
- IgG
- Top Product
- Discover our top product VEGFR2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
-
-
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis." in: Journal of biochemistry and molecular biology, Vol. 39, Issue 5, pp. 469-78, (2006) (PubMed).
: "
-
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis." in: Journal of biochemistry and molecular biology, Vol. 39, Issue 5, pp. 469-78, (2006) (PubMed).
-
- Target
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
- Andere Bezeichnung
- VEGF RECEPTOR 2 (VEGFR2 Produkte)
- Hintergrund
- Synonyms: KDR
- Gen-ID
- 3791
- UniProt
- P35968
- Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
-